Portuguese companies at the Real Estate Show in Paris
BAS, PLMJ and RFF announced they will be present at the 6th Portuguese Real Estate and Tourism Show which will take place from May 12 to 14 in Paris, France. Read the full article
Funchal debates Public Procurement and Litigation
JM-Madeira, in partnership with the Center for Judicial Studies and the Madeira Regional Council of the Portuguese Bar Association, will hold a conference on “Pre-Contractual
Sérvulo and BAS lawyers will debate about public procurement in Funchal
Sérvulo and BAS lawyers will attend the conference “Contracting and pre-contractual litigation – in the light of the revised public procurement code”, which will
Health: When data protection demands special attention
The sensitive nature of health data demands a specific assessment of the impact of the new General Regulation on Data Protection. An analysis of Cláudia Monge, lawyer and partner
Rebenta a Bolha! (The game is over)
Artur Filipe da Silva, lawyer and partner at BAS, wrote about the appreciation of the Portuguese real estate market at Jornal Económico: The phrase “rebenta a bolha”,
BAS lawyers at EELA meeting
BAS announces its presence at the European Employment Lawyers Association (EELA) annual meeting, in Zurich, Switzerland, until this Saturday, June 10th. Click here to read the Advo
BAS lawyers at the annual EELA meeting
BAS is at the annual European Employment Lawyers Association (EELA) meeting … Click here to read the Advogar article.
Sports Law seen out of the box
Ricardo Costa, columnist for Record newspaper, is one of the coordinators of the Sports Law event that ends today. Mention to the presence of Pedro Madeira de Brito, lawyer and pa
New general regulation for data protection
A year after the definitive entry into force of the new RGPD, Jane Kirkby and Claudia Monge, BAS’s partners, underline the most relevant aspects of this new regulation in the las
New rules for transparency in advertising
Jane Kirkby, BAS’s attorney and partner, looks at the concept of Beneficiary Entities in the new rules for transparency in advertising of drugs and medical devices. Read the
